Title: Nuclear Medicine in Neurology and Psychiatry

Abstract

Nuclear medicine in Neurology and Psychiatry involve the use of different radiopharmaceuticals exhibiting uptake by brain and imaged using emission tomography (SPECT or PET). Most radiopharmaceuticals detect perfusion or metabolic abnormalities of the brain, and some radiotracers bind with basal ganglia receptors. Newer compounds bind to abnormal cerebral deposition of proteins such as amyloid. After basic introduction of Nuclear Imaging Cerebrovascular disease, epilepsy, neurodegenerative disorders and dementia (especially Alzheimer’s disease) brain tumours and other neurological and psychiatric disorders will be discussed with examples.